INORGANIC NANOMATERIALS PATH FROM DESIGN TO COMMERCIALIZATION
INORGANIC NANOMATERIALS PATH FROM DESIGN TO COMMERCIALIZATION
AviXéla is committed to being a member in the National Nanotechnology Initiative scientific community, which is sustainable and beneficial in safe use of technology and nanomaterials across all industries. Our team works to explore the better understanding of nanotechnology role in the national economic development and environment. We are primarily involved in the research, development, manufacturing, utilization, and marketing of nanotechnology-enabled products and processes, technical and engineering services needed for their production, including all forms of information technology. From strategic planning to project management, we offer a wide range of services that are tailored to meet the unique needs of your production through streamline manufacturing operations and maximizing companies’ growth potential.
AviXéla story began with a passion for personalized, results-driven consulting and a mission to provide services for the early-stage investigators and business owners. We were primarily involved in the design of sponsored grants in compliance with government policies and procedures. Our team responded to clients’ needs and assisted them in a comprehensive screening of projects available at the state, federal, and non-profit funding levels, including SBIR and STTR grants initiatives. Today, we continue to uphold that same passion and commitment to excellence.
With the pace of scientific innovation and the prior experience in the industry and academic setting, including Columbia University Medical Center, Cornell University, New York University Medical Center, Westchester Medical Center, Washington State University, Nagasaki University, Medical School, Cognate Therapeutics, and Bristol Myers Squibb, collaboration on the national and global level, our members followed institutional standards and designed the aligned translational and fundamental research applications funded through National Institute of Health (NIH) and non-profit organization level. Leading this mission, we integrated this interdisciplinary experience in the development and implementation of innovative synthesis systems, methods, and technologies through precise evaluation of rapidly developed research field of nanomaterials (NMs) due to their unique electrical, optical, magnetic, and catalytic properties.
AviXéla centers on development of nanodelivery systems and programmed release of procedures and materials to specific industrial targets. Owing to its unique physical and chemical properties compared to either small molecules or other bulk materials, these nanomaterials have multiple applications in the fields of agricultural and consumer products, green energy, information technology, energy nanomedicine, and nanotools for treatment and diagnostic purposes in the healthcare.
Our team specifically focus on discovering novel support and/or multimetallic systems conducive for the development of catalytic NPs that are highly active, selective, stable, robust, and inexpensive.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.